An anti-aging drug for dogs promises to win owners more time with old pets. It could be FDA-approved soon.
This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. Have an account? .
An anti-aging drug for dogs is one step closer to doctor's offices, after it cleared a key regulatory hurdle with the US Food and Drug Administration (FDA) earlier this month.
On Tuesday, Loyal announced that its first-of-its-kind longevity drug received the first of three green lights needed for FDA approval. The decision, made in early November, is essentially a vote of confidence from federal regulators that this drug should actually work to extend dogs' lifespans, based on evidence so far.
Loyal's new drug, called LOY-001 is an injection that dogs over 7 years and 40 pounds could receive at their veterinarian's office roughly every three to six months.
The goal? Add more years of healthy living onto the pets' lives, at a relatively reasonable price of "mid double digits" a month, Loyal CEO and founder Celine Halioua told Business Insider. Halioua expects the drug, which aims to slow down big dog growth factors, could be on the market in 2026.
But if this anti-aging drug is successfully approved by the FDA, it could be a watershed moment not only for pet owners, but for aging humans, too. This is the first time that US regulators have hinted that they could be ready to endorse longevity drugs.
"Classically, drugs are developed for diseases," Halioua explained. "What the longevity field is trying to do is target the ways we age holistically."
Instead of going after one disease at a time, the new drugs that Loyal (and other biotech companies) are currently developing for longevity hope to extend the amount of time that dogs and people can be reasonably expected to live in good health.
"Extend out those healthy middle years," as Halioua put it.
There are several other longevity trials, ongoing in both dogs and in people, testing out drugs both new and old that aging scientists hope could help slow down the clock. So far, there's never been any drug approved to combat aging, but many experts are hopeful that a breakthrough moment in the field could be hiding just around the corner.
Read next
Hilary Brueck is a Health Correspondent at Business Insider, where she covers longevity and the quest to improve human aging. She also writes regularly about new developments in exercise science, expert-backed nutrition advice, the complexities of diagnosing and treating cancer, and the evolving landscape of GLP-1 drugs. In general, she relishes any opportunity to unpack human health discoveries or examine the latest health and wellness trends. Her reports have ranged from exploring how sherpas effortlessly climb into the thin air 29,029 feet above sea level to summit Mount Everest, to trudging along a Jersey shore beach with scientists fighting killer pandemic flu viruses by studying bird butts.She spoke with Dr. Anthony Fauci about his vitamin and supplement routine over a cold slice of pizza, and chatted with the world's oldest Nobel Prize winner in his basement solar lab. She also went an entire month without eating any ultra-processed foods (yes, it was time-consuming and challenging). A graduate of Columbia Journalism School and former Peace Corps Volunteer, Hilary speaks English, French, and Malagasy. Previously, Hilary reported for ABC News Radio, Fortune, Forbes, and Al Jazeera America. In her spare time, she likes to run, hike and she is also an aspiring (but very bad) surfer. If you've got a pressing health question, tip, or concern, reach out to hbrueck@businessinsider.comExpertise
- Longevity and healthy aging
- GLP1s like Ozempic and Mounjaro
- Exercise and nutrition science
- Brain-Computer Interfaces (Neuralink, Synchron)
- Mental health and wellness
Awards
- 2026 National Headliner Award: first place for online beat reporting in health & science for a series on young colon cancer.
- 2025 North American Travel Journalists Association silver award for sports, recreation, and adventure writing.
- 2024 New York Press Club award for best online infographic: What loneliness does to your body and brain
- 2024 James Beard nominee for health and wellness reporting: Long-Lived Loma Linda
Popular Articles Forget supplements — 3 daily habits have a much bigger impact on extending your lifespanThe under-the-radar injections people are taking to build muscle this summer — including the 'Wolverine' shotA 42-year-old thought blood in the toilet was pregnancy-related hemorrhoids. She had colorectal cancer.Chickpeas can significantly lower your cholesterol. Here are 5 tasty recipes scientists recommend to improve your health.5 simple ways to be a better friend, according to Harvard experts who have studied relationships for decadesA psychiatry researcher who taught his students depression was caused by a 'chemical imbalance' in the brain says everything he thought he knew about SSRIs is wrong
This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. Have an account? .